[Cl:1][C:2]1[S:6][C:5]([S:7]([NH:10][C@H:11]([CH:16]=[O:17])[C@@H:12]([CH3:15])[CH2:13][CH3:14])(=[O:9])=[O:8])=[CH:4][CH:3]=1.[Si]([C:22]([F:25])([F:24])[F:23])(C)(C)C.CCCC[N+](CCCC)(CCCC)CCCC.[F-]>C1COCC1>[Cl:1][C:2]1[S:6][C:5]([S:7]([NH:10][C@H:11]([CH:16]([OH:17])[C:22]([F:25])([F:24])[F:23])[C@@H:12]([CH3:15])[CH2:13][CH3:14])(=[O:9])=[O:8])=[CH:4][CH:3]=1To a 0° C. solution of 5-chlorothiophene-2-sulfonyl isoleucinal (770 mg, 2.6 mmol, see Example 118, parts 1&2) in THF (5 mL) was added TMS-CF3 (5 mL, 0.5M in THF). The resulting mixture was treated with TBAF (250 μL, 1M in THF). The cold bath was removed and the reaction was stirred at 25° C. overnight. The reaction was quenched with HCl (25 mL, 2M) and the resulting solution was extracted with ethyl acetate (3×15 mL). The combined organic extracts were washed with water (25 mL) and brine (25 mL) then dried over MgSO4. The residue was submitted to RP-HPLC (see example 155 for procedure) to give 74 mg of the desired product (m/z=364.0 (M−H), rt=1.23 min).
読み込み中…